Strolll secures Innovate UK loan and grant package alongside IW-led investment
The neurorehabilitation company is advancing an AI-enabled clinical validation platform.
Rehabilitation that extends beyond the clinic
Strolll delivers neurorehabilitation exercises through augmented-reality glasses, using visual prompts to guide movement while patients remain aware of their surroundings. Therapists can tailor the activities for mobility, balance or gait work, with the same approach supporting prescribed practice at home between appointments.
The Innovate UK loan is tied to StrolllAssessment, an AI-enabled biomechanics-lab platform intended to let multiple clinical validation studies run in parallel. The announced package also includes a separate grant award; the company disclosed a parallel IW Capital-led equity investment but did not state its amount.
Use of funds
Develop StrolllAssessment and advance clinical validation